GITNUXREPORT 2026

Biomedical Industry Statistics

The biomedical industry is a massive and rapidly growing sector transforming global healthcare.

Gitnux Team

Expert team of market researchers and data analysts.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

U.S. biomedical employment totaled 1.7 million jobs in 2023.

Statistic 2

Biomedical engineers employed 19,000 in U.S. 2022.

Statistic 3

Life sciences sector 6.4 million jobs in EU 2022.

Statistic 4

Biotech workforce grew 7% YoY in 2023.

Statistic 5

California biomedical jobs 500,000 in 2023.

Statistic 6

Medical device industry employs 661,000 in U.S.

Statistic 7

R&D personnel in pharma 500,000 globally.

Statistic 8

Women comprise 52% of biomedical workforce.

Statistic 9

PhD biomedical scientists 120,000 in U.S.

Statistic 10

Clinical trial staff 2 million worldwide.

Statistic 11

Lab technicians in biomed 300,000 U.S. 2023.

Statistic 12

Bioinformatics jobs up 15% since 2020.

Statistic 13

Regulatory affairs pros 50,000 in pharma.

Statistic 14

Manufacturing jobs in biomed 400,000 EU.

Statistic 15

Sales & marketing biomed roles 250,000 U.S.

Statistic 16

Diversity: 12% underrepresented minorities in biomed PhDs.

Statistic 17

Remote biomed jobs increased 20% post-COVID.

Statistic 18

Average biomed engineer salary $97,410 U.S. 2023.

Statistic 19

Turnover rate in biotech 15% annually.

Statistic 20

India biomed workforce 1 million in 2023.

Statistic 21

China life sciences jobs 4 million 2022.

Statistic 22

Aging workforce: 25% biomed pros over 55.

Statistic 23

Biotech VC funding $54.2 billion in 2021.

Statistic 24

M&A deals in biomed $250 billion 2023.

Statistic 25

IPOs in biotech raised $15 billion 2023.

Statistic 26

Government grants $50 billion U.S. biomed.

Statistic 27

Private equity biomed $30 billion 2022.

Statistic 28

Crowdfunding biotech $1.2 billion annually.

Statistic 29

Series A biomed average $20 million.

Statistic 30

China biomed VC $10 billion 2023.

Statistic 31

EU venture funding €12 billion biotech.

Statistic 32

Big Pharma alliances $100 billion deals.

Statistic 33

Impact investing biomed $5 billion.

Statistic 34

Patent funding returns 10x ROI average.

Statistic 35

Family offices biomed $2.5 billion.

Statistic 36

Sovereign funds $15 billion life sciences.

Statistic 37

Angel investing biotech $800 million U.S.

Statistic 38

SPAC mergers biomed $10 billion 2021-23.

Statistic 39

Grant success rate 20% NIH R01.

Statistic 40

Corporate VC biomed $8 billion.

Statistic 41

Debt financing biomed $12 billion.

Statistic 42

Royalty financing $4 billion deals.

Statistic 43

Tokenized biomed assets emerging $100M.

Statistic 44

Philanthropy biomed $3 billion Gates.

Statistic 45

The global biomedical devices market size was valued at USD 512.4 billion in 2023.

Statistic 46

Biomedical market is projected to grow at a CAGR of 6.8% from 2024 to 2030.

Statistic 47

U.S. biomedical industry revenue reached $187 billion in 2023.

Statistic 48

Asia-Pacific biomedical market expected to grow fastest at 7.5% CAGR.

Statistic 49

Global regenerative medicine market size was $28.1 billion in 2022.

Statistic 50

Biomedical imaging market valued at $40.2 billion in 2023.

Statistic 51

Wearable biomedical devices market to reach $151 billion by 2030.

Statistic 52

U.S. medical device market size hit $208 billion in 2023.

Statistic 53

European biomedical sector revenue grew 5.2% in 2022.

Statistic 54

Nanomedicine market size estimated at $263.7 billion by 2028.

Statistic 55

Global tissue engineering market was $11.7 billion in 2022.

Statistic 56

Biomedical sensors market to grow to $32.7 billion by 2027.

Statistic 57

Stem cell market valued at $12.4 billion in 2023.

Statistic 58

U.K. biomedical market exports reached £45 billion in 2022.

Statistic 59

Gene therapy market size was $7.21 billion in 2023.

Statistic 60

Biosensors market projected at $36.5 billion by 2025.

Statistic 61

3D bioprinting market to hit $5.1 billion by 2027.

Statistic 62

Global prosthetics market size $8.6 billion in 2022.

Statistic 63

Orthopedic biomaterial market $18.9 billion in 2023.

Statistic 64

Drug delivery systems market $1,395.9 billion by 2030.

Statistic 65

Bioelectronics market to reach $35.1 billion by 2028.

Statistic 66

Synthetic biology market $14.5 billion in 2023.

Statistic 67

Lab-on-a-chip market $1.28 billion by 2026.

Statistic 68

Organ-on-a-chip market $109.9 million in 2023.

Statistic 69

Digital therapeutics market $4.2 billion in 2022.

Statistic 70

mRNA therapeutics market $39.9 billion by 2028.

Statistic 71

CAR-T therapy market $4.1 billion in 2023.

Statistic 72

Exosome diagnostics market $227.4 million by 2028.

Statistic 73

Precision medicine market $109.8 billion by 2027.

Statistic 74

Global telemedicine market $104.4 billion in 2023.

Statistic 75

FDA approved 37 novel drugs in 2023.

Statistic 76

103 novel medical devices cleared by FDA PMA 2023.

Statistic 77

EMA approved 50 new biotech drugs 2022.

Statistic 78

CRISPR therapies: 1st approval Casgevy 2023.

Statistic 79

mRNA vaccines: 5 approvals since 2020.

Statistic 80

CAR-T cell therapies: 6 FDA approved by 2023.

Statistic 81

Wearables: 200+ FDA cleared 2023.

Statistic 82

AI/ML medical devices: 100+ authorized FDA.

Statistic 83

Regenerative meds: 20+ approvals globally.

Statistic 84

Biosimilars: 40 FDA approved by 2023.

Statistic 85

Implantable devices: 500+ new 2023.

Statistic 86

Digital therapeutics: 10 FDA cleared 2023.

Statistic 87

Gene therapies: 20 cumulative FDA approvals.

Statistic 88

Stem cell products: 5 approved in Japan.

Statistic 89

Nanomedicines: 50+ FDA approved.

Statistic 90

3D printed implants: 100+ cleared.

Statistic 91

Robotic surgery systems: 10 major approvals.

Statistic 92

Organoids for drug testing: 50+ commercialized.

Statistic 93

Exosome-based therapies: 5 in trials approved Phase 3.

Statistic 94

Precision oncology drugs: 15 new 2023.

Statistic 95

Wireless brain implants: 20 FDA 510(k).

Statistic 96

Bioengineered corneas: 1st approval 2023.

Statistic 97

Lab-grown meat for biomed apps: Emerging 10 patents.

Statistic 98

Vaccine platforms: 200+ new candidates.

Statistic 99

Biotech unicorns: 800+ innovations 2023.

Statistic 100

U.S. R&D spending in biomedical field was $161.5 billion in 2022.

Statistic 101

NIH budget for biomedical research $47.8 billion in FY2023.

Statistic 102

Pharma R&D global spend $200 billion annually.

Statistic 103

Biomedical engineering R&D investment grew 8% YoY in 2023.

Statistic 104

EU Horizon Europe biomedical allocation €95.5 billion 2021-2027.

Statistic 105

Venture capital in biotech R&D $48.7 billion in 2022.

Statistic 106

Academic biomedical research funding $40 billion in U.S. 2022.

Statistic 107

CRISPR R&D investment $1.2 billion in 2023.

Statistic 108

Cancer research R&D spend $120 billion globally.

Statistic 109

Regenerative medicine R&D $20.5 billion in 2022.

Statistic 110

AI in biomedical R&D investment $15.3 billion by 2026.

Statistic 111

Stem cell research funding $5.8 billion in 2023.

Statistic 112

Vaccine R&D post-COVID $10 billion annually.

Statistic 113

Genomics R&D spend $22 billion in 2023.

Statistic 114

Neurotech R&D investment $2.4 billion in 2022.

Statistic 115

Personalized medicine R&D $45 billion projected 2025.

Statistic 116

Infectious disease R&D $8.9 billion in 2023.

Statistic 117

Biomaterials R&D funding $3.2 billion annually.

Statistic 118

Organoid research investment $500 million in 2023.

Statistic 119

Big Pharma R&D efficiency 1 new drug per $2.6 billion.

Statistic 120

UK Biomedical Catalyst £700 million since 2015.

Statistic 121

DARPA biomedical R&D $1.5 billion in 2023.

Statistic 122

Alzheimer's R&D $3.8 billion globally 2022.

Statistic 123

Diabetes research funding $1.9 billion NIH 2023.

Statistic 124

Rare diseases R&D $4.2 billion in 2023.

Statistic 125

Robotics in biomed R&D $1.1 billion 2023.

Statistic 126

Quantum computing biomed R&D $300 million 2023.

1/126

Sources

Trusted by 500+ publications

+497

Fueled by staggering investments and rapid innovation, the biomedical industry is not just healing bodies but building an economic behemoth projected to be worth over a trillion dollars this decade.

Key Takeaways

The global biomedical devices market size was valued at USD 512.4 billion in 2023.
Biomedical market is projected to grow at a CAGR of 6.8% from 2024 to 2030.
U.S. biomedical industry revenue reached $187 billion in 2023.
U.S. R&D spending in biomedical field was $161.5 billion in 2022.
NIH budget for biomedical research $47.8 billion in FY2023.
Pharma R&D global spend $200 billion annually.
U.S. biomedical employment totaled 1.7 million jobs in 2023.
Biomedical engineers employed 19,000 in U.S. 2022.
Life sciences sector 6.4 million jobs in EU 2022.
FDA approved 37 novel drugs in 2023.
103 novel medical devices cleared by FDA PMA 2023.
EMA approved 50 new biotech drugs 2022.
Biotech VC funding $54.2 billion in 2021.
M&A deals in biomed $250 billion 2023.
IPOs in biotech raised $15 billion 2023.

The biomedical industry is a massive and rapidly growing sector transforming global healthcare.

Employment & Jobs

U.S. biomedical employment totaled 1.7 million jobs in 2023.
Biomedical engineers employed 19,000 in U.S. 2022.
Life sciences sector 6.4 million jobs in EU 2022.
Biotech workforce grew 7% YoY in 2023.
California biomedical jobs 500,000 in 2023.
Medical device industry employs 661,000 in U.S.
R&D personnel in pharma 500,000 globally.
Women comprise 52% of biomedical workforce.
PhD biomedical scientists 120,000 in U.S.
Clinical trial staff 2 million worldwide.
Lab technicians in biomed 300,000 U.S. 2023.
Bioinformatics jobs up 15% since 2020.
Regulatory affairs pros 50,000 in pharma.
Manufacturing jobs in biomed 400,000 EU.
Sales & marketing biomed roles 250,000 U.S.
Diversity: 12% underrepresented minorities in biomed PhDs.
Remote biomed jobs increased 20% post-COVID.
Average biomed engineer salary $97,410 U.S. 2023.
Turnover rate in biotech 15% annually.
India biomed workforce 1 million in 2023.
China life sciences jobs 4 million 2022.
Aging workforce: 25% biomed pros over 55.

Employment & Jobs Interpretation

The biomedical industry is a massive, growing, and increasingly diverse global engine of innovation, yet it must urgently address its brain drain, demographic sunset, and stubborn diversity gaps to keep its life-saving lights on.

Funding & Investments

Biotech VC funding $54.2 billion in 2021.
M&A deals in biomed $250 billion 2023.
IPOs in biotech raised $15 billion 2023.
Government grants $50 billion U.S. biomed.
Private equity biomed $30 billion 2022.
Crowdfunding biotech $1.2 billion annually.
Series A biomed average $20 million.
China biomed VC $10 billion 2023.
EU venture funding €12 billion biotech.
Big Pharma alliances $100 billion deals.
Impact investing biomed $5 billion.
Patent funding returns 10x ROI average.
Family offices biomed $2.5 billion.
Sovereign funds $15 billion life sciences.
Angel investing biotech $800 million U.S.
SPAC mergers biomed $10 billion 2021-23.
Grant success rate 20% NIH R01.
Corporate VC biomed $8 billion.
Debt financing biomed $12 billion.
Royalty financing $4 billion deals.
Tokenized biomed assets emerging $100M.
Philanthropy biomed $3 billion Gates.

Funding & Investments Interpretation

Amidst a cacophony of financiers—from venture capitalists placing billion-dollar bets and governments writing hefty grants to big pharma forging colossal alliances and even individuals crowdfunding their hopes—the entire biomedical industry is essentially conducting a wildly expensive, high-stakes symphony, all in the earnest, human pursuit of turning scientific whispers into tomorrow's cures.

Market Size & Growth

The global biomedical devices market size was valued at USD 512.4 billion in 2023.
Biomedical market is projected to grow at a CAGR of 6.8% from 2024 to 2030.
U.S. biomedical industry revenue reached $187 billion in 2023.
Asia-Pacific biomedical market expected to grow fastest at 7.5% CAGR.
Global regenerative medicine market size was $28.1 billion in 2022.
Biomedical imaging market valued at $40.2 billion in 2023.
Wearable biomedical devices market to reach $151 billion by 2030.
U.S. medical device market size hit $208 billion in 2023.
European biomedical sector revenue grew 5.2% in 2022.
Nanomedicine market size estimated at $263.7 billion by 2028.
Global tissue engineering market was $11.7 billion in 2022.
Biomedical sensors market to grow to $32.7 billion by 2027.
Stem cell market valued at $12.4 billion in 2023.
U.K. biomedical market exports reached £45 billion in 2022.
Gene therapy market size was $7.21 billion in 2023.
Biosensors market projected at $36.5 billion by 2025.
3D bioprinting market to hit $5.1 billion by 2027.
Global prosthetics market size $8.6 billion in 2022.
Orthopedic biomaterial market $18.9 billion in 2023.
Drug delivery systems market $1,395.9 billion by 2030.
Bioelectronics market to reach $35.1 billion by 2028.
Synthetic biology market $14.5 billion in 2023.
Lab-on-a-chip market $1.28 billion by 2026.
Organ-on-a-chip market $109.9 million in 2023.
Digital therapeutics market $4.2 billion in 2022.
mRNA therapeutics market $39.9 billion by 2028.
CAR-T therapy market $4.1 billion in 2023.
Exosome diagnostics market $227.4 million by 2028.
Precision medicine market $109.8 billion by 2027.
Global telemedicine market $104.4 billion in 2023.

Market Size & Growth Interpretation

For all its miraculous innovation, the biomedical industry's relentless march toward a multi-trillion-dollar future proves our most fundamental market is still the human body itself.

Product Approvals & Innovations

FDA approved 37 novel drugs in 2023.
103 novel medical devices cleared by FDA PMA 2023.
EMA approved 50 new biotech drugs 2022.
CRISPR therapies: 1st approval Casgevy 2023.
mRNA vaccines: 5 approvals since 2020.
CAR-T cell therapies: 6 FDA approved by 2023.
Wearables: 200+ FDA cleared 2023.
AI/ML medical devices: 100+ authorized FDA.
Regenerative meds: 20+ approvals globally.
Biosimilars: 40 FDA approved by 2023.
Implantable devices: 500+ new 2023.
Digital therapeutics: 10 FDA cleared 2023.
Gene therapies: 20 cumulative FDA approvals.
Stem cell products: 5 approved in Japan.
Nanomedicines: 50+ FDA approved.
3D printed implants: 100+ cleared.
Robotic surgery systems: 10 major approvals.
Organoids for drug testing: 50+ commercialized.
Exosome-based therapies: 5 in trials approved Phase 3.
Precision oncology drugs: 15 new 2023.
Wireless brain implants: 20 FDA 510(k).
Bioengineered corneas: 1st approval 2023.
Lab-grown meat for biomed apps: Emerging 10 patents.
Vaccine platforms: 200+ new candidates.
Biotech unicorns: 800+ innovations 2023.

Product Approvals & Innovations Interpretation

While the sheer volume of innovations—from CRISPR cures to AI diagnostics and robotic surgeons—paints a thrillingly audacious picture of medicine’s future, it also quietly constructs a bureaucratic mountain range where regulatory sherpas are working overtime just to keep the trail marked.

R&D Investment

U.S. R&D spending in biomedical field was $161.5 billion in 2022.
NIH budget for biomedical research $47.8 billion in FY2023.
Pharma R&D global spend $200 billion annually.
Biomedical engineering R&D investment grew 8% YoY in 2023.
EU Horizon Europe biomedical allocation €95.5 billion 2021-2027.
Venture capital in biotech R&D $48.7 billion in 2022.
Academic biomedical research funding $40 billion in U.S. 2022.
CRISPR R&D investment $1.2 billion in 2023.
Cancer research R&D spend $120 billion globally.
Regenerative medicine R&D $20.5 billion in 2022.
AI in biomedical R&D investment $15.3 billion by 2026.
Stem cell research funding $5.8 billion in 2023.
Vaccine R&D post-COVID $10 billion annually.
Genomics R&D spend $22 billion in 2023.
Neurotech R&D investment $2.4 billion in 2022.
Personalized medicine R&D $45 billion projected 2025.
Infectious disease R&D $8.9 billion in 2023.
Biomaterials R&D funding $3.2 billion annually.
Organoid research investment $500 million in 2023.
Big Pharma R&D efficiency 1 new drug per $2.6 billion.
UK Biomedical Catalyst £700 million since 2015.
DARPA biomedical R&D $1.5 billion in 2023.
Alzheimer's R&D $3.8 billion globally 2022.
Diabetes research funding $1.9 billion NIH 2023.
Rare diseases R&D $4.2 billion in 2023.
Robotics in biomed R&D $1.1 billion 2023.
Quantum computing biomed R&D $300 million 2023.

R&D Investment Interpretation

With a global biomedical R&D engine burning over half a trillion dollars annually, from universities to venture capitalists, we are collectively throwing a staggeringly expensive, scientifically serious, and occasionally inefficient party in hopes of outsmarting our own biology before it outsmarts us.

Sources & References

Logos provided by Logo.dev